BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,113 | -72.8% | 331,707 | -75.7% | 0.02% | -75.0% |
| Q1 2023 | $55,465 | +6.3% | 1,367,492 | +33.6% | 0.07% | -1.4% |
| Q4 2022 | $52,182 | -99.9% | 1,023,788 | +15.2% | 0.07% | +2.8% |
| Q3 2022 | $47,873,000 | -63.4% | 888,845 | -56.4% | 0.07% | -61.6% |
| Q2 2022 | $130,902,000 | -36.9% | 2,038,019 | -23.8% | 0.18% | -28.6% |
| Q1 2022 | $207,357,000 | +52.1% | 2,674,196 | +68.4% | 0.26% | +55.1% |
| Q4 2021 | $136,346,000 | +10.2% | 1,588,376 | +3.2% | 0.17% | +7.7% |
| Q3 2021 | $123,764,000 | -35.5% | 1,538,773 | -35.5% | 0.16% | -34.3% |
| Q2 2021 | $192,008,000 | -26.4% | 2,385,189 | -22.9% | 0.24% | -32.4% |
| Q1 2021 | $260,954,000 | +29.6% | 3,094,077 | +23.3% | 0.35% | +22.9% |
| Q4 2020 | $201,323,000 | +55.8% | 2,509,014 | +56.1% | 0.28% | +38.5% |
| Q3 2020 | $129,258,000 | +24.3% | 1,607,281 | +33.1% | 0.20% | +7.3% |
| Q2 2020 | $103,993,000 | +141.4% | 1,207,814 | +127.6% | 0.19% | +57.9% |
| Q1 2020 | $43,088,000 | +4195.9% | 530,706 | +4322.6% | 0.12% | +5950.0% |
| Q4 2019 | $1,003,000 | -64.1% | 12,000 | -66.9% | 0.00% | -66.7% |
| Q3 2018 | $2,791,000 | +96.8% | 36,200 | +88.5% | 0.01% | +100.0% |
| Q2 2018 | $1,418,000 | -55.2% | 19,200 | -60.6% | 0.00% | -57.1% |
| Q1 2018 | $3,167,000 | -73.7% | 48,700 | -74.6% | 0.01% | -78.1% |
| Q3 2017 | $12,029,000 | -91.8% | 191,701 | -92.1% | 0.03% | -92.8% |
| Q2 2017 | $146,663,000 | +117.2% | 2,422,575 | +86.0% | 0.44% | +79.0% |
| Q1 2017 | $67,532,000 | – | 1,302,194 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |